Want to see SE:LINC full AI Analyst Report?
LINC Stock Chart & Stats
kr69.40
-kr0.60(-0.89%)
At close: 4:00 PM EST
kr69.40
-kr0.60(-0.89%)
Day’s Range― - ―
52-Week Rangekr58.90 - kr83.60
Previous CloseN/A
Volume35.92K
Average Volume (3M)47.06K
Market Cap
kr4.12B
Enterprise Valuekr3.81B
Total Cash (Recent Filing)kr234.02M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)9.9
Beta0.73
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding57,910,446
10 Day Avg. Volume58,577
30 Day Avg. Volume47,060
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.91
Price to Sales (P/S)415.95
P/FCF Ratio-15.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Debt-free Balance SheetA zero-debt balance sheet materially lowers financing and solvency risk over the next 2-6 months, giving management flexibility to fund follow-on investments or weather portfolio drawdowns without urgent external financing, supporting durable capital allocation optionality.
Life-science Focused Investment ModelA concentrated, sector-focused active ownership model provides durable competitive advantages: specialized sourcing, operational guidance, and exit know-how in life sciences. This increases odds of value creation from portfolio development and strategic exits over medium term horizons.
Reported Revenue GrowthA reported ~21% revenue growth metric suggests recent expansion in underlying activities or portfolio-derived revenues. Sustained top-line growth over months improves the base for recurring distributions or higher valuation on exits, improving medium-term realization prospects.
Bears Say
Weak Cash GenerationNegative operating and free cash flow over the TTM period reduces internal funding available for follow-on investments, dividends, or deal support. Over 2-6 months this limits financial flexibility and may force asset sales or external funding at inopportune times.
Uneven Earnings QualityProfitability driven by non-operating gains and volatile revenue undermines predictability of recurring earnings. Reliance on valuation-driven results makes sustainable profit generation uncertain and complicates planning for distributions or reinvestment over the medium term.
Declining Equity And Volatile ROEA shrinking equity base and swings in ROE indicate inconsistent value creation and reduced capital buffer. Persisting downward equity trends can weaken resilience to losses and limit capacity to support portfolio companies without dilutive or costly capital raises.
LINC FAQ
What was Linc AB’s price range in the past 12 months?
Linc AB lowest stock price was kr58.90 and its highest was kr83.60 in the past 12 months.
What is Linc AB’s market cap?
Linc AB’s market cap is kr4.12B.
When is Linc AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Linc AB’s earnings last quarter?
Currently, no data Available
Is Linc AB overvalued?
According to Wall Street analysts Linc AB’s price is currently Overvalued.
Does Linc AB pay dividends?
Linc AB does not currently pay dividends.
What is Linc AB’s EPS estimate?
Linc AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Linc AB have?
Linc AB has 57,910,446 shares outstanding.
What happened to Linc AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Linc AB?
Currently, no hedge funds are holding shares in SE:LINC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Linc AB
Linc AB operates as a private equity and venture capital firm, dedicating its investments to the pharmaceutical, life sciences, and med-tech sectors across early, mid, and late venture stages. The firm prioritizes investment opportunities within Nordic companies. Its typical investment amounts range from SEK 25 million to SEK 250 million, frequently beginning with a relatively smaller initial capital injection, with subsequent follow-up investments constituting the majority of its financial commitment. Linc AB's headquarters are located in Stockholm, Sweden.
Technical Analysis
Creades AB
―
Idun Industrier AB Class B
―
Vo2 Cap Holding AB
―
Svolder AB Class B
―
MedCap AB
―
Options Prices
Currently, No data available
---